Cargando…
Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496444/ https://www.ncbi.nlm.nih.gov/pubmed/34630338 http://dx.doi.org/10.3389/fendo.2021.760153 |
| _version_ | 1784579760432611328 |
|---|---|
| author | Meier, Juris J. Gallwitz, Baptist Giorgino, Francesco |
| author_facet | Meier, Juris J. Gallwitz, Baptist Giorgino, Francesco |
| author_sort | Meier, Juris J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8496444 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84964442021-10-08 Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations Meier, Juris J. Gallwitz, Baptist Giorgino, Francesco Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2021-09-23 /pmc/articles/PMC8496444/ /pubmed/34630338 http://dx.doi.org/10.3389/fendo.2021.760153 Text en Copyright © 2021 Meier, Gallwitz and Giorgino https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology Meier, Juris J. Gallwitz, Baptist Giorgino, Francesco Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
| title | Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
| title_full | Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
| title_fullStr | Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
| title_full_unstemmed | Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
| title_short | Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
| title_sort | editorial: reviews and novel clinical perspectives on semaglutide: a glp-1 receptor agonist with both injectable and oral formulations |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496444/ https://www.ncbi.nlm.nih.gov/pubmed/34630338 http://dx.doi.org/10.3389/fendo.2021.760153 |
| work_keys_str_mv | AT meierjurisj editorialreviewsandnovelclinicalperspectivesonsemaglutideaglp1receptoragonistwithbothinjectableandoralformulations AT gallwitzbaptist editorialreviewsandnovelclinicalperspectivesonsemaglutideaglp1receptoragonistwithbothinjectableandoralformulations AT giorginofrancesco editorialreviewsandnovelclinicalperspectivesonsemaglutideaglp1receptoragonistwithbothinjectableandoralformulations |